HELENA – Montana will receive nearly $152,000 in Medicaid restitution and penalties as part of a settlement recently negotiated between the National Association of Medicaid Fraud Control Units and pharmaceutical manufacturer Parke-Davis, a division of Warner-Lambert. The Medicaid fraud settlement is separate from a recent consumer-protection settlement with Warner-Lambert.
Warner-Lambert will pay $152 million in damages and penalties to states' Medicaid programs as part of an agreement that resolves allegations of a massive "off-label" marketing campaign for the epilepsy medication Neurontin. "Off-label" describes a use of a medication other than the use for which the drug is approved. Although doctors may prescribe drugs for off-label purposes, it is illegal for manufacturers to promote those off-label uses.
Read More....
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment